期刊文献+

高效液相色谱法测定氯诺昔康薄膜衣片的溶出度 被引量:3

Dissolution determination of lornoxicam from film-coated tablets by HPLC
下载PDF
导出
摘要 目的采用高效液相色谱法法定量测定氯诺昔康薄膜衣片的溶出曲线。方法HPLC法采用ShimadzuVPODS柱(4.6mm×150mm,5μm),流动相为0.05mol·L-1醋酸钠(pH5.8)甲醇(52∶48),检测波长为379nm。溶出度测定采用中国药典2000年版二部溶出度测定法第三法装置。结果在浓度9.72~22.68mg·L-1范围内,线性方程为C=9.5628×10-5A+0.1005,r=0.9999,3种剂量组的回收率分别为99.68%(RSD0.48%),100.5%(RSD0.39%)和100.3%(RSD0.69%),重复性好,精密度高。3批样品溶出迅速,批间差异小。结论本法简单,专属性强,可准确用于氯诺昔康薄膜衣片溶出度的测定。 OBJECFIVE To establish an HPLC method for the quantitative determination of lornoxicam from film-coated tablets. METHODS The HPLC procedure was performed on Shimadzu ODS (4.6mm×150mm,5μm) column maintained. The mobile phase was the degassed mixture of sodium acetate (0.05mol·L^-1, pH 5.8) and methanol (55 : 45). The detection was set at 379 nm The dissolution tests were performed according to China Pharmacopoeia 2000 dissolution test apparatus Ⅲ. RESULTS The linearity range was 9. 72- 22. 68 mol·L^-1 (r= 0. 999 9). Mean recovery was from 99. 68%to 100.5%. Precision of the method was found to be 0. 67%. Rapid dissolution of lornoxicam from three batches of film-coated tablets was observed. CONCLUSION The simple HPLC method with good specificity may be used for the accurate dissolution determination of lornoxicam film-coated tablets.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2005年第5期447-448,共2页 Chinese Journal of Hospital Pharmacy
关键词 氯诺昔康 薄膜衣片 高效液相色谱法 溶出曲线 lornoxicam film-coated tablets HPLC dissolution profile
  • 相关文献

参考文献2

  • 1Staunstrup H,Ovesen J,Larsen UT,etal. Efficacy and tolerability of lomoxicam versus tramadol in postoperative pain[J]. J Clin Pharmacol, 1999,39 (8):834.
  • 2樊伟明,吴峰,翁杭辉,丁建明,任秉钧.氯诺昔康的合成[J].中国医药工业杂志,2002,33(8):365-366. 被引量:6

二级参考文献1

共引文献5

同被引文献19

  • 1周舍典,王莉,徐峰,李梅.55例患者应用氯诺昔康镇痛效果及其不良反应回顾性调查[J].中国药房,2005,16(5):376-377. 被引量:7
  • 2高缘,张建军,樊伟明,任秉钧.氯诺昔康注射剂的研制——处方前溶解度研究[J].中国现代应用药学,2006,23(3):207-209. 被引量:6
  • 3Balfour JA, Fitton A, Barradell LB. Lornoxicam: review of its pharmacology and therapeutic potential in the management of painful and inflammatory conditions [J]. Drugs, 1996, 51 (4): 639.
  • 4Rosenow DE, AlbrechtsenM, Stolke D. A comparison of patient controlIed analgesia with lornoxicam versus morphine in patientsundergoing lumbar disk surgery [J]. Anesth Analg,1998, 86 (5) : 1045.
  • 5Martin Del Valle EM. Cyclodextrins and their uses: a review [J]. Process Biochem, 2004, (39): 1033-1046.
  • 6Sohajda T, Beni S, Varga E, et al. Characterization of aspar tame-cyclodextrin complexation [J]. J Pharm Biomed Anal, 2009, 50 (5): 737- 745.
  • 7Radhofer-Welte S, Dittrich P. Determination of the novel nonsteroidal anti inflammatory drug lornoxicam and its main metab olite in plasma and synovial fluid [J]. J Chromatogr B, 1998, 707 (1 2): 151-159.
  • 8Gladys G, Marcela L. Thermal analysis and spectroscopic characterization of interactions between a naphthoquinone derivative with HP -β- CD or PVP [J]. Pharm Dev Tech, 2002, 7 (3):381-390.
  • 9Oha I, Leea MY, Lee YB, et al. Spectroscopic characterization of ibuprofen/2 hydroxypropyl β eyclodextrin inclusion complex [J]. IntJPharm, 1998, 175 (2): 215 223.
  • 10Loukas, Yannis L. Evaluation of the methods for the determination of the stability constant of cyclodextrin chlorambucil inclusion complexes [J]. J Pharm Biomed Anal, 1997, 16 (2):275- 280.

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部